Topical Modulation of Burn Wound Healing
Topical Modulation of Burn Wound Healing
批准号:
7481972
负责人:
DAVID J VACHON
金额:
$19.77万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-05 至 2010-12-31
关键词:
AddressAffectAlkanesulfonatesAnimalsAnti-Bacterial AgentsAntibioticsAntioxidantsAreaArginineBiochemicalBlood flowBurn injuryCathepsin GCationsCeriumCharacteristicsChemical BurnsClinicalComb animal structureComplexControl GroupsCoupledDataDepthDermalDevelopmentDialysis procedureDoxycyclineDrug FormulationsEffectivenessElastasesEndopeptidasesEvaluationFunctional disorderGelGelatinase BGlutathioneHealedHistologyHumanHydrogelsImpaired wound healingIn VitroIndividualInflammationInflammatoryInflammatory ResponseInjuryIon ExchangeIonsLipidsLiquid substanceMCC protocolMarketingMatrix Metalloproteinase InhibitorMeasurementMediator of activation proteinMetalsModelingNecrosisNeutrophil CollagenaseNitric OxideNutrientOutcomePSSO3Pancreatic ElastasePeptide HydrolasesPeroxidasePersonsPhysical DialysisPolymersPreparationProtease InhibitorProteinsPublic HealthPurposeRadiationRattusReactive Oxygen SpeciesRecoveryRegulationRodentRodent ModelSaltsScreening procedureSepsisSerine ProteaseSimulateSodium ChlorideSolutionsSterile coveringsSurfaceTestingTherapeuticTherapeutic AgentsThickTimeTissuesToxinUnited StatesUnited States Food and Drug AdministrationWaterWound HealingWounds and InjuriesZincantimicrobialbaseclinically relevantcost effectivenessdirect applicationhealingheat injuryimprovedin vivoinhibitor/antagonistleukocyte activationneutrophilnovelpreventresponseskin disordertherapy designwound
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Our central hypothesis is that the inflammatory response to thermal injury results in an imbalance of endogenous proteases and their inhibitors resulting in impaired healing. In this collaborative effort, we propose that burn wound healing can be improved through the use of topical wound dressings with the capacity to affect key mediators involved in the inflammatory response. The therapeutic agent IMS-70, which has demonstrated an intrinsic ability to inhibit neutrophil-derived proteases, will be evaluated as a healing component of our wound treatment(s). We predict that the majority of improvement will occur in the zone of stasis. Our hypothesis will be tested with the following specific aims:
Specific Aim 1): Formulation and in vitro screening of IMS-70 & Derivatives
IMS-70 will be chemically modified to incorporate the antibiotic and MMP inhibitor, doxycycline; the reactive oxygen species scavenger, glutathione; the antimicrobial cerium ion, and the nutrient arginine. In vitro screening will be performed to test the ability of these derivatives to inhibit proteases such as neutrophil-derived elastase, cathepsin G, MMP-8 and MMP-9 and neutrophil- derived myeloperoxidase.
Specific Aim 2): In vivo testing of IMS-70 & Derivatives.
The IMS-70 derivatives will be blended into a CMC amorphous hydrogel carrier and applied to a burn wound in the rat. This model generates areas of full- thickness burn separated by non-burned interspaces representing the zone of stasis. The efficacy of the dressings will be tested by comparing histology, protease activity, and inflammatory markers to a control group receiving only the hydrogel carrier.
Successful completion of the specific aims outlined in this proposal will provide the necessary data to optimize topical therapies for use in larger surface area burns, potentially limiting the systemic effects that result in burn wound sepsis, burn wound conversion, and prolonged recovery. PUBLIC HEALTH RELEVANCE Project Narrative: Thermal injury triggers a complex inflammatory response that can result in extensive damage to the unburned tissues. In this proposal we describe the development and testing of novel topical therapies designed to limit the inflammatory response and thereby reduce the extent of burn wound injury. These basic mechanisms will also apply to chemical burns and radiation induced injury, as well as other inflammatory diseases of the skin.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Self-Assembling Gel with Antimicrobial and Antioxidant Properties for the Treat
-
批准号:8597978
-
项目类别:
-
资助金额:$34.92万
-
财政年份:2013
-
负责人:DAVID J VACHON
-
依托单位:
Treatment of Wound Infection with Novel Uncharged Silver Carbene Complexes
-
批准号:8453014
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2012
-
负责人:DAVID J VACHON
-
依托单位:
A Novel Electrospun Vascular Graft
-
批准号:7805685
-
项目类别:
-
资助金额:$27.78万
-
财政年份:2010
-
负责人:DAVID J VACHON
-
依托单位:
Peptide-Modified Sulfonated Styrene Block Copolymers for Vascular Applications
-
批准号:7393608
-
项目类别:
-
资助金额:$16.15万
-
财政年份:2008
-
负责人:DAVID J VACHON
-
依托单位:
A Novel & Tailorable Drug Delivery Device for the Treatment of Periodontitis
-
批准号:7537768
-
项目类别:
-
资助金额:$15.85万
-
财政年份:2008
-
负责人:DAVID J VACHON
-
依托单位:
A Novel & Tailorable Topical Wound Therapy Based on a Semi-Interpenetrating Polym
-
批准号:7275122
-
项目类别:
-
资助金额:$14.13万
-
财政年份:2007
-
负责人:DAVID J VACHON
-
依托单位:
PROTEASE MODULATING WOUND DRESSINGS FOR THE TREATMENT OF VENOUS ULCERS
-
批准号:6998556
-
项目类别:
-
资助金额:$19.66万
-
财政年份:2006
-
负责人:DAVID J VACHON
-
依托单位:
Synthesis and Processing of Sulfonated Block Copolymer Biomaterials
-
批准号:7109992
-
项目类别:
-
资助金额:$9.85万
-
财政年份:2006
-
负责人:DAVID J VACHON
-
依托单位:
Novel Cation-Exchange Wound Dressing for Diabetic Ulcers
-
批准号:6834243
-
项目类别:
-
资助金额:$10.84万
-
财政年份:2004
-
负责人:DAVID J VACHON
-
依托单位:
Novel Wound Dressing for Chronic Ulcers
-
批准号:6550024
-
项目类别:
-
资助金额:$9.98万
-
财政年份:2002
-
负责人:DAVID J VACHON
-
依托单位:
海外基金